跳至主要内容
临床试验/NCT05162339
NCT05162339已完成不适用

Inflammatory Bowel Disease and Thromboembolic Events

Centro Hospitalar Tondela-Viseu1 个研究点 分布在 1 个国家目标入组 149 人开始时间: 2016年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
149
试验地点
1
主要终点
Prevalence of thromboembolic events in IBD

研究概览

简要总结

The main objective was to demonstrate the existence and importance of hypercoagulability in patients with IBD, by determining the prevalence of changes in coagulation parameters and evaluating the impact of these changes on the occurrence of thromboembolic events.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with 18 years of age or older, diagnosed with IBD, followed at a gastroenterology consultation at Centro Hospitalar Tondela-Viseu, between November 2016 and April 2017.

排除标准

  • Individuals with other risk factors for TE (severe hepatic or renal failure, valvular heart disease, atrial fibrillation, heart failure or cardiomyopathy, pregnancy, and oral anticoagulants or heparin at the baseline).

结局指标

主要结局

Prevalence of thromboembolic events in IBD

时间窗: 36 months

To evaluate the coagulation parameters and the prevalence of thromboembolic events in IBD patients

Coagulation parameters variations in IBD

时间窗: 36 months

To investigate the correlation between coagulation parameters and disease phenotype and activity.

次要结局

未报告次要终点

研究者

发起方
Centro Hospitalar Tondela-Viseu
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ana Carvalho

Principal Investigator

Centro Hospitalar Tondela-Viseu

研究点 (1)

Loading locations...

相似试验